US Patent 10221126 Solabegron zwitterion and uses thereof
Patent 10221126 was granted and assigned to Velicept Therapeutics on March, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
June 26, 2018
0
Date of Patent
March 5, 2019
0
Patent Applicant
Patent Application Number
16018945
0
Patent Citations Received
Patent Inventor Names
Raymond E. Stevens
0
Bingidimi Itute Mobele
0
Dalian Zhao
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10221126 Solabegron zwitterion and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
